Mebrofenin Pregnancy and Breastfeeding Warnings
Brand names: Choletec
Mebrofenin Pregnancy Warnings
Animal reproduction studies have not been conducted.
It is not known whether Tc99m mebrofenin can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity.
FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
FDA pregnancy category: C
Use mebrofenin only if clearly needed and benefit outweighs potential risk.
Mebrofenin Breastfeeding Warnings
The manufacturer recommends substitution of formula feedings for breast feedings.
Breast-feeding is not recommended.
Excreted into human milk: Yes
Excreted into animal milk: Unknown
The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Product Information. Choletec (mebrofenin). Bracco Diagnostics Inc. 2012.
References for breastfeeding information
- Product Information. Choletec (mebrofenin). Bracco Diagnostics Inc. 2012.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
